Trials / Recruiting
RecruitingNCT06689956
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective Multicenter Single-Arm Observational Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 212 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study evaluates whether isolated tumor cells in the first lymph nodes near the tumor can tell researchers something important about the future of patients with a certain type of endometrial (uterine) cancer.
Detailed description
PRIMARY OBJECTIVE: I. To evaluate whether the likelihood of disease recurrence differs between a prospective cohort of patients with low-risk endometrial cancer with ITC and an historical cohort with negative SLNs. OUTLINE: This is an observational study. Patients undergo tissue sample collection and have their medical records reviewed on study.
Conditions
- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
- FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
- Stage IA1 Endometrial Cancer FIGO 2023
- Stage IA2 Endometrial Cancer FIGO 2023
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-Interventional Study |
Timeline
- Start date
- 2024-12-04
- Primary completion
- 2029-10-31
- Completion
- 2029-10-31
- First posted
- 2024-11-15
- Last updated
- 2026-02-19
Locations
20 sites across 10 countries: United States, Austria, Brazil, Canada, France, Germany, Israel, Italy, Spain, Switzerland
Source: ClinicalTrials.gov record NCT06689956. Inclusion in this directory is not an endorsement.